Approval · Notice of Compliance 36474 · 2025
AMOXICILLIN: Notice of Compliance 36474
Issued December 3, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36474
- Date
- December 3, 2025
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to labelling (to match Licensor)
- Canadian reference product
- APO-AMOXI (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 500 MG per CAP